NO172118C - Analogifremgangsmaate til fremstilling av terapeutisk aktivt n-(omega-substituert -alkyl)-n'-((imidazol-4-yl)alkyl)-guanidin - Google Patents

Analogifremgangsmaate til fremstilling av terapeutisk aktivt n-(omega-substituert -alkyl)-n'-((imidazol-4-yl)alkyl)-guanidin

Info

Publication number
NO172118C
NO172118C NO880745A NO880745A NO172118C NO 172118 C NO172118 C NO 172118C NO 880745 A NO880745 A NO 880745A NO 880745 A NO880745 A NO 880745A NO 172118 C NO172118 C NO 172118C
Authority
NO
Norway
Prior art keywords
alkyl
pct
imidazol
guanidine
omega
Prior art date
Application number
NO880745A
Other languages
English (en)
Norwegian (no)
Other versions
NO880745L (no
NO172118B (no
NO880745D0 (no
Inventor
Geert Jan Sterk
Henk Timmerman
Henk Van Der Goot
Original Assignee
Cedona Pharm Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cedona Pharm Bv filed Critical Cedona Pharm Bv
Publication of NO880745L publication Critical patent/NO880745L/no
Publication of NO880745D0 publication Critical patent/NO880745D0/no
Publication of NO172118B publication Critical patent/NO172118B/no
Publication of NO172118C publication Critical patent/NO172118C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Polyurethanes Or Polyureas (AREA)
  • Inks, Pencil-Leads, Or Crayons (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO880745A 1986-06-19 1988-02-19 Analogifremgangsmaate til fremstilling av terapeutisk aktivt n-(omega-substituert -alkyl)-n'-((imidazol-4-yl)alkyl)-guanidin NO172118C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL8601585A NL8601585A (nl) 1986-06-19 1986-06-19 N-(2-gesubstitueerde alkyl)-n-imidazol-4-yl alkyl guanidine.
PCT/NL1987/000013 WO1987007891A1 (en) 1986-06-19 1987-06-19 N-(2-substituted alkyl)-n'-[(imidazole-4-yl)alkyl]guanidine

Publications (4)

Publication Number Publication Date
NO880745L NO880745L (no) 1988-02-19
NO880745D0 NO880745D0 (no) 1988-02-19
NO172118B NO172118B (no) 1993-03-01
NO172118C true NO172118C (no) 1993-06-09

Family

ID=19848186

Family Applications (1)

Application Number Title Priority Date Filing Date
NO880745A NO172118C (no) 1986-06-19 1988-02-19 Analogifremgangsmaate til fremstilling av terapeutisk aktivt n-(omega-substituert -alkyl)-n'-((imidazol-4-yl)alkyl)-guanidin

Country Status (15)

Country Link
US (1) US5010095A (da)
EP (1) EP0302896B1 (da)
JP (1) JPH01502981A (da)
KR (1) KR880701231A (da)
AT (1) ATE66212T1 (da)
CA (1) CA1296716C (da)
DE (1) DE3772202D1 (da)
DK (1) DK81288D0 (da)
FI (1) FI885861A0 (da)
HU (1) HUT56548A (da)
MC (1) MC1936A1 (da)
NL (1) NL8601585A (da)
NO (1) NO172118C (da)
RU (1) RU1802811C (da)
WO (1) WO1987007891A1 (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL9000132A (nl) * 1990-01-19 1991-08-16 Cedona Pharm Bv Nieuwe thiazoolderivaten.
NL9100365A (nl) * 1991-02-27 1992-09-16 Seed Capital Investments Imidazoolderivaten met agonistische of antagonistische activiteit op de histamine h3-receptor.
CA2104946A1 (en) * 1991-02-27 1992-08-28 Hendrik Timmerman Imidazole-derivatives having agonistic or antagonistic activity on the histamine h3-receptor
USRE37303E1 (en) * 1992-01-10 2001-07-31 Institut National Del La Sante Et De La Recherche Medicale Imidazole compounds and their therapeutic applications
FR2686084B1 (fr) * 1992-01-10 1995-12-22 Bioprojet Soc Civ Nouveaux derives de l'imidazole, leur preparation et leurs applications therapeutiques.
US5424447A (en) * 1993-07-07 1995-06-13 The Medical College Of Wisconsin Research Foundation, Inc. Heme binding compounds and use thereof
US6448282B1 (en) 1995-05-30 2002-09-10 Gliatech, Inc. 1H-4(5)-substituted imidazole derivatives
JPH11506106A (ja) * 1995-05-30 1999-06-02 グリアテツク・インコーポレイテツド 1h−4(5)−置換イミダゾール誘導体
US6127343A (en) * 1996-05-14 2000-10-03 Novo Nordisk A/S Somatostatin agonists and antagonists
AU2764797A (en) * 1996-05-14 1997-12-05 Novo Nordisk A/S Somatostatin agonists and antagonists
AU4772497A (en) * 1996-10-31 1998-05-22 Novo Nordisk A/S Constrained somatostatin agonists and antagonists
US6225332B1 (en) * 1997-10-21 2001-05-01 Alcon Laboratories, Inc. Compositions containing histamine H2 agonists and methods of use in treating allergy and inflammation
JP2005526024A (ja) * 2002-02-08 2005-09-02 スミスクライン ビーチャム コーポレーション インスリン分泌を阻害するための化合物及びそれに関連する方法
DE10245212B4 (de) * 2002-09-27 2008-01-03 Ivoclar Vivadent Ag Verwendung säurehaltiger Mittel zur Desensibilisierung von Zähnen

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4013659A (en) * 1973-07-13 1977-03-22 Smith Kline & French Laboratories Limited Certain n,n'-disubstituted guanidine compounds and their use
IL49528A (en) * 1975-05-21 1980-11-30 Smith Kline French Lab Imidazolyl(or thiazolyl)methylthio(or butyl)guanidine or thiourea derivatives,their preparation and pharmaceutical compositions comprising them
US4192879A (en) * 1975-05-21 1980-03-11 Smith Kline & French Laboratories Limited Imidazolyl alkylamino nitroethylene compounds
US4166860A (en) * 1977-10-11 1979-09-04 William H. Rorer, Inc. Imidazole amidinoureas for stimulating H2 -receptors
DE3512084A1 (de) * 1985-04-02 1986-10-09 Ludwig Heumann & Co GmbH, 8500 Nürnberg Guanidinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3528214A1 (de) * 1985-08-06 1987-02-12 Heumann Ludwig & Co Gmbh Arylalkylguanidinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3528215A1 (de) * 1985-08-06 1987-02-12 Heumann Ludwig & Co Gmbh Heteroarylalkylguanidinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Also Published As

Publication number Publication date
AU604727B2 (en) 1991-01-03
DE3772202D1 (de) 1991-09-19
EP0302896B1 (en) 1991-08-14
EP0302896A1 (en) 1989-02-15
DK81288A (da) 1988-02-17
NL8601585A (nl) 1988-01-18
HUT56548A (en) 1991-09-30
NO880745L (no) 1988-02-19
US5010095A (en) 1991-04-23
FI885861A (fi) 1988-12-19
NO172118B (no) 1993-03-01
KR880701231A (ko) 1988-07-26
ATE66212T1 (de) 1991-08-15
DK81288D0 (da) 1988-02-17
AU7589387A (en) 1988-01-12
RU1802811C (ru) 1993-03-15
NO880745D0 (no) 1988-02-19
MC1936A1 (fr) 1989-05-19
CA1296716C (en) 1992-03-03
WO1987007891A1 (en) 1987-12-30
JPH01502981A (ja) 1989-10-12
FI885861A0 (fi) 1988-12-19

Similar Documents

Publication Publication Date Title
NO172118C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktivt n-(omega-substituert -alkyl)-n'-((imidazol-4-yl)alkyl)-guanidin
KR920021523A (ko) 신규한 우레아 유도체, 이의 제조 방법 및 이들을 함유하는 약제학적 조성물
DE69022453D1 (de) N-(3-Hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro-2H-benzopyran oder dihydrobenzodioxin)-carboxamid-Derivate.
NO874454D0 (no) Nye derivater av benzimidazoler med anti-ulcusaktivitet og fremgangsmaate for deres fremstilling.
KR910015562A (ko) 뇌부전 질환치료용 약제, 신규 2-(1-피페라지닐)-4-페닐시클로알카노 피리미딘 유도체, 및 그의 제법
DK597687D0 (da) Imidazolidinonforbindelse, fremgangsmaade til fremstilling deraf og farmaceutisk praeparat dermed
ATE89547T1 (de) Dopamin-vorlaeufer.
DE3774795D1 (de) Phenoxyessigsaeure-verbindungen, ihre herstellung, pharmazeutische zusammensetzungen und deren verwendung.
ES2028838T3 (es) Procedimiento para la obtencion de nuevos derivados de 4,5-hidro-oxazoles.
DK166281C (da) Tetrahydroisoxazoloe4,5-caapyridin derivater og farmaceutisk acceptable syreadditionssalte deraf, farmaceutiske praeparater indeholdende disse forbindelser, og fremgangsmaade til deres fremstilling
DE2236876B2 (de) N-Substituierte Aminocarbonsäuren und diese Verbindungen enthaltende Arzneimittel
DE69910738D1 (de) Fungizide zusammensetzung enthaltend ein n-benzoyl-n'-phenyl-harnstoff derivat
US3098008A (en) Method for treatment of dermatological disorders
ES8708213A1 (es) Un procedimiento para preparar un derivado de 1-benzhidril--4-cinamilpiperazina
DE3782235D1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur prophylaxe und zur behandlung von herzinsuffizienz.
ATE105476T1 (de) Dihydropyridin-verbindung zur verbesserung der adernausdehnung und hemmung der herzhypertrophie.
KR910002789A (ko) 아크릴산염, 이것의 제조방법, 이것을 함유한 제약조성물 및 의약에서 이것을 사용하는 방법
TH2131B (th) การเตรียมอนุพันธ์ของเบนซิมิดาโซลและสารผสมของสารเหล่านี้
ATE44741T1 (de) 2-(n-substituierte guanidino)-4heteroarylthiazole als mittel gegen geschwuere.